SCHEMBL24250882

SCHEMBL24250882

CC(C)C(=O)CCOCCOCCOCCOCCNC(=O)CCCCC1SCC2NC(=O)NC21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.66
▸ PRSS1 P07477 1/20 0.66
▸ PRSS2 P07478 1/20 0.66
▸ PRSS3 P35030 1/20 0.66
▸ TPSAB1 Q15661 1/20 0.66
▸ FOLH1 Q04609 7/20 0.65
▸ PKM P14618 3/20 0.62
▸ TDP1 Q9NUW8 5/20 0.59
▸ HSP90AB1 P08238 1/20 0.59
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ABL1 P00519 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ IDE P14735 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ RIN1 Q13671 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24250876 0.92 F2 (0.66) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL18897174 0.92 TDP1 (0.61) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL26208079 0.91 PKM (0.63) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL23879992 0.91 F2 (0.67) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL19017236 0.91 F2 (0.73) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL19751698 0.91 F2 (0.73) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL4968230 0.91 F2 (0.73) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL15216220 0.91 F2 (0.73) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL14748707 0.90 FOLH1 (0.69) F2PRSS1PRSS2PRSS3TPSAB1
SCHEMBL17126770 0.90 F2 (0.67) F2PRSS1PRSS2PRSS3TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140838-A9 NOVEL ACTIVITY-BASED PROBES FOR NEUTROPHIL ELASTASE AND THEIR USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-05-04 — — US disclosed
US-20220050107-A1 NOVEL ACTIVITY-BASED PROBES FOR NEUTROPHIL ELASTASE AND THEIR USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-02-17 — — US disclosed
Send feedback